AnaptysBio’s $100 Million Stock Repurchase Plan Underscores Strong Cash Position and Strategic Shift
Market Chameleon (Fri, 21-Nov 8:56 AM)
Anaptys Sets Sights on Split: Biopharma and Royalty Businesses to Operate Independently by 2026
Market Chameleon (Tue, 30-Sep 10:31 AM)
